Peter Georgakopoulos

Summary

Publications

  1. ncbi Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up
    Peter Georgakopoulos
    Hematology Unit of the Third University Department of Sotiria Hospital of Athens, Athens, Greece
    Am J Hematol 85:894-6. 2010

Detail Information

Publications1

  1. ncbi Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up
    Peter Georgakopoulos
    Hematology Unit of the Third University Department of Sotiria Hospital of Athens, Athens, Greece
    Am J Hematol 85:894-6. 2010
    ..No association was found between the presence of cardiotoxicity and concomitant treatment or other variable apart of age that had a significant impact. The marginal benefit seen with metoprolol should be investigated further...